- $45.73m
- $35.56m
- $52.35m
- 34
- 47
- 35
- 33
Annual balance sheet for Apyx Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 58.8 | 41.9 | 30.9 | 10.2 | 43.7 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 9.22 | 17.3 | 21.3 | 18.3 | 14.2 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 76.7 | 66.1 | 60.7 | 43 | 70.4 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7.62 | 7.21 | 6.87 | 7.59 | 7.15 |
| Other Long Term Assets | |||||
| Total Assets | 84.7 | 74.1 | 68.7 | 51.8 | 79.2 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 12.3 | 9.15 | 13.2 | 11.8 | 12.7 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 13.5 | 10.4 | 15 | 14.2 | 52.5 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 71.3 | 63.7 | 53.7 | 37.6 | 26.7 |
| Total Liabilities & Shareholders' Equity | 84.7 | 74.1 | 68.7 | 51.8 | 79.2 |
| Total Common Shares Outstanding |